Ivosidenib (IDH1 Inhibitor)

Treatment used for 1 condition

Total Trials
20
Total Participants
0K
Avg Effectiveness
40%
Avg Safety Score
45%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.